Abu-El-Haija Basil, Giudici Michael C
Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
Clin Cardiol. 2014 Jun;37(6):381-5. doi: 10.1002/clc.22276. Epub 2014 Apr 3.
Electrical cardioversion (EC) for atrial fibrillation (AF) is a common procedure performed in an attempt to restore normal sinus rhythm (NSR). Many factors predict long-term maintenance of NSR and the risk of AF recurrence. The duration of AF, cardiac size and function, rheumatic heart disease, significant mitral valve disease, left atrial enlargement, and older age are among the most common recognized factors. A number of interventions can potentially decrease the AF recurrence rate. Identifying and treating reversible causes and the use of antiarrhythmic medications in certain situations can help decrease the risk of AF recurrence. The role of the newer anticoagulants is expanding, and wider application is expected in the near future. We hope that this summary will serve as a guide to physicians and healthcare providers to address the question of who should undergo cardioversion, as there are patients who are most likely to benefit from this procedure and others that will revert back into AF within a short period. To identify who would benefit most from EC and have a reasonable chance of long-term maintenance of NSR, a thorough evaluation of each individual patient should be performed to tailor the best therapy to each individual.
心房颤动(AF)的电复律(EC)是一种常见的操作,旨在恢复正常窦性心律(NSR)。许多因素可预测NSR的长期维持及AF复发风险。AF持续时间、心脏大小和功能、风湿性心脏病、显著二尖瓣疾病、左心房扩大及高龄是最常见的公认因素。一些干预措施可能降低AF复发率。识别和治疗可逆病因以及在某些情况下使用抗心律失常药物有助于降低AF复发风险。新型抗凝药物的作用正在扩大,预计在不久的将来会得到更广泛应用。我们希望本综述能为医生和医疗服务提供者提供指导,以解决谁应接受复律这一问题,因为有些患者最可能从该操作中获益,而其他患者则会在短期内复发为AF。为了确定谁能从EC中获益最大并有合理机会长期维持NSR,应对每位患者进行全面评估,以便为其量身定制最佳治疗方案。